AlphaCrest Capital Management’s Health Catalyst HCAT Stock Holding History

AlphaCrest Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,060	Closed	-$224K	–	502
2022 Q3	$224K	Sell	23,060 -120,119	-84%	-$1.59M	0.01%	1218
2022 Q2	$2.08M	Buy	143,179 +81,238	+131%	+$1.39M	0.1%	296
2022 Q1	$1.62M	Sell	61,941 -8,282	-12%	-$235K	0.09%	327
2021 Q4	$2.78M	Buy	70,223 +37,570	+115%	+$1.71M	0.1%	259
2021 Q3	$1.63M	Sell	32,653 -8,494	-21%	-$463K	0.08%	395
2021 Q2	$2.28M	Buy	41,147 +34,347	+505%	+$1.83M	0.1%	315
2021 Q1	$318K	Sell	6,800 -10,900	-62%	-$528K	0.02%	999
2020 Q4	$770K	Buy	+17,700	New	+$653K	0.06%	430

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AlphaCrest Capital Management's HCAT Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 23,060 shares — an estimated $224K sold.

AlphaCrest Capital Management first reported a position in HCAT in Q4 2020 and held it in 8 quarters. The position peaked at $2.78M in Q4 2021. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

AlphaCrest Capital Management reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 23,060 Health Catalyst shares in Q4 2022, an estimated $224K.
AlphaCrest Capital Management first reported a position in Health Catalyst in Q4 2020 and held it in 8 quarters.
AlphaCrest Capital Management's Health Catalyst position peaked at $2.78M in Q4 2021.
167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.